Soreide Law Group has received calls from clients who purchased Cytori Therapeutics, Inc. (CYTX) and have suffered significant stock losses.  This security was offered by brokers at Laidlaw and Company, who were also the underwriter of the offering. Newly issued securities are typically more volatile than older more established companies, and if as an investor […]